background
human
bocaviru
hbov
new
speci
genu
parvoviru
newli
detect
seem
worldwid
distribut
pathogen
among
children
respiratori
tract
infect
preval
recent
publish
retrospect
studi
one
prospect
birth
cohort
studi
suggest
hbovprimari
infect
occur
infant
method
prospect
singl
center
studi
one
winter
season
novemb
hospit
children
without
age
restrict
use
pcrbase
diagnost
method
result
hbov
dna
detect
nasopharyng
aspir
symptomat
hospit
children
median
age
month
rang
month
rsv
hmpv
hcov
influenza
b
detect
n
n
n
n
respect
influenza
dna
detect
specimen
clinic
diagnos
acut
wheez
bronchiti
four
patient
radiolog
confirm
pneumonia
six
patient
croup
syndrom
one
patient
five
six
patient
pneumonia
hbov
pathogen
detect
patient
mechan
ventil
need
oxygen
supplement
four
patient
least
one
viral
pathogen
found
plu
rsv
n
noroviru
n
conclus
hbov
caus
sever
respiratori
tract
infect
infant
young
children
role
copathogen
mani
open
question
defin
prospect
studi
human
bocaviru
hbov
first
describ
alland
et
al
karolinska
univers
hospit
stockholm
viru
identifi
retrospect
analyz
clinic
specimen
infant
children
respiratori
tract
infect
rti
hbov
seem
worldwid
distribut
pathogen
frequent
associ
respiratori
tract
infect
among
infant
young
children
hbovposit
patient
also
present
symptom
gastrointestin
diseas
arnold
et
al
kesebir
et
al
hbov
dna
recent
detect
stool
sampl
patient
unrel
respiratori
infect
vicent
et
al
rais
question
differ
possibl
mode
transmiss
unlik
patient
rsvinfect
ogra
simon
et
al
similar
hmpvassoci
respiratori
tract
infect
children
older
month
seem
risk
kesebir
et
al
man
et
al
weissbrich
et
al
point
report
infect
adult
popul
bastien
et
al
man
et
al
sloot
et
al
detect
hbov
possibl
rtpcr
alland
et
al
modifi
real
time
rtpcr
protocol
recent
publish
klein
et
al
lin
et
al
lu
et
al
schenk
et
al
detect
copiesml
respiratori
secret
symptomat
patient
hitherto
anim
model
method
viru
cultur
avail
koch
revis
postul
yet
fulfil
hbov
well
design
clinic
studi
investig
associ
viru
respiratori
possibl
gastrointestin
manifest
arnold
et
al
kesebir
et
al
howev
statist
signific
associ
hbov
detect
previous
unexplain
diseas
alland
et
al
alland
et
al
significantli
higher
frequenc
hbov
dna
detect
symptomat
asymptomat
individu
alland
et
al
alland
et
al
kesebir
et
al
support
idea
possibl
associ
viru
clinic
symptom
coinfect
viral
pathogen
frequent
confirm
featur
hbov
infect
rais
question
causal
alland
et
al
kaplan
et
al
smut
hardi
children
hospit
univers
bonn
viral
rti
prospect
investig
multicent
surveil
studi
sinc
report
discuss
prospect
document
viral
rti
hospit
pediatr
patient
winter
season
focus
hbov
infect
detect
put
result
perspect
analyz
public
alland
et
al
arnold
et
al
bastien
et
al
choi
et
al
foulongn
et
al
b
kaplan
et
al
kesebir
et
al
klein
et
al
lin
et
al
lu
et
al
et
al
man
et
al
regamey
et
al
schenk
et
al
sloot
et
al
smut
hardi
weissbrich
et
al
deal
hbovinfect
novemb
specif
softwar
tool
develop
institut
target
surveil
hospit
rsvinfect
pediatr
patient
made
avail
data
entri
inclus
criteria
detail
surveil
protocol
publish
recent
simon
et
al
databas
modifi
reopen
clinic
data
entri
consid
pathogen
caus
viral
respiratori
tract
infect
virti
ped
databas
simon
et
al
b
wilkesmann
et
al
purpos
prospect
analysi
pediatr
inpati
hospit
novemb
may
virolog
confirm
rsv
hmpv
hcov
hbov
infect
includ
irrespect
age
year
underli
diseas
comorbid
whether
infect
acquir
hospit
home
lower
respiratori
tract
infect
document
pneumonia
chest
radiograph
confirm
clinic
diagnosi
donnelli
studi
protocol
virti
ped
studi
approv
ethic
committe
univers
bonn
enrol
data
entri
databas
inform
consent
obtain
parent
patient
legal
guardian
nasopharyng
specimen
patient
suffer
respiratori
ill
test
previous
describ
follow
virus
rtpcr
human
coronavirus
sar
describ
rtpcr
human
metapneumoviru
schildgen
et
al
viazov
et
al
wilkesmann
et
al
rtpcr
rsv
elisa
inver
medic
cologn
germani
respiratori
syncyti
viru
human
influenza
virus
b
influenza
ab
elisa
inver
medic
cologn
germani
human
bocaviru
alland
et
al
kupfer
et
al
simon
et
al
except
human
coronavirus
method
describ
detail
previous
alland
et
al
kupfer
et
al
schildgen
et
al
simon
et
al
viazov
et
al
wilkesmann
et
al
amplif
hcovspecif
sequenc
rna
extract
nasopharyng
aspir
qiaamp
minelut
viru
spin
kit
qiagen
hilden
germani
subject
singleround
rtpcr
qiagen
hilden
germani
use
set
primer
design
basi
comparison
pol
sequenc
known
human
coronavirus
kupfer
et
al
rt
carri
min
c
follow
pcr
one
initi
step
denatur
c
min
cycl
amplif
c
c
c
final
elong
step
c
min
primer
use
pancoronaviru
pcr
tca
cay
ttw
gga
tar
tcc
ca
act
car
atr
aat
ctt
aar
tay
gc
act
caa
atr
aat
ttr
aar
tay
gc
final
concentr
pcramplicon
length
basepair
electrophores
agaros
gel
visual
ethidium
bromid
stain
posit
pcr
result
especi
posit
human
bocaviru
confirm
sequenc
common
respiratori
virus
human
parainfluenza
viru
human
rhinovirus
adenoviru
includ
screen
panel
amplicon
purifi
use
qiaquick
pcr
purif
kit
qiagen
hilden
germani
subject
sequenc
direct
bigdy
termin
dna
sequenc
kit
appli
biosystem
darmstadt
germani
previous
describ
schildgen
et
al
blastn
http
wwwncbinlmnihgovblast
use
comparison
obtain
sequenc
nucleotid
sequenc
databas
novemb
may
nasopharyng
aspir
npa
hospit
pediatr
patient
respiratori
tract
infect
investig
specimen
n
patient
posit
hbov
rsv
hmpv
hcov
influenza
b
virus
detect
n
n
n
n
respect
influenzaviru
detect
taken
togeth
investig
children
least
one
viral
pathogen
includ
diagnost
panel
could
detect
patient
hbov
infect
found
decemb
fig
proport
hbovposit
specimen
refer
investig
specimen
vari
correspond
month
surveil
fig
median
age
hbovposit
patient
month
rang
month
eight
male
median
durat
symptom
admiss
hospit
day
rang
day
median
durat
hospit
day
rang
day
one
patient
preexist
comorbid
prematur
birth
birth
weight
g
clinic
diagnosi
acut
wheez
bronchiti
four
patient
pneumonia
six
patient
croup
syndrom
one
patient
eight
hbovposit
patient
attend
physician
order
chest
radiograph
yield
patholog
find
seven
patient
one
peribronch
four
bronchopneumonia
two
lobar
pneumonia
five
six
patient
radiolog
confirm
pneumonia
hbov
pathogen
detect
patient
mechan
ventil
need
oxygen
supplement
median
leukocyt
count
diagnosi
l
rang
l
median
creactiv
protein
mgl
normal
rang
mgl
patient
receiv
treatment
betamimet
inhal
system
steroid
antimicrobi
chemotherapi
consid
patient
rsvcoinfect
attend
physician
awar
viral
pathogen
time
clinic
event
besid
one
patient
hbov
detect
two
consecut
day
two
respiratori
specimen
follow
investig
perform
hbovposit
patient
pathogen
detect
least
one
viral
pathogen
found
plu
rsv
n
noroviru
n
report
repres
first
prospect
investig
hospit
pediatr
patient
hbov
infect
although
proport
hbovposit
specimen
studi
rel
low
rang
literatur
bastien
et
al
kaplan
et
al
ill
sever
remark
radiolog
confirm
pneumonia
need
oxygen
supplement
major
patient
anoth
recent
publish
prospect
studi
detect
hbov
five
infant
rti
birth
cohort
studi
switzerland
regamey
et
al
infant
mild
diseas
none
hospit
defin
definit
role
hbov
respiratori
pathogen
prospect
populationbas
multicentr
studi
perform
author
observ
higher
preval
hbovinfect
cold
winter
spring
month
alland
et
al
regamey
et
al
smut
hardi
choi
et
al
corea
choi
et
al
report
rel
high
occurr
hbov
late
spring
earli
summer
bastien
et
al
canada
detect
hbov
throughout
year
appar
season
preval
data
collect
month
novemb
may
therefor
contribut
evalu
incid
hbov
warm
month
summer
earli
fall
nevertheless
show
steadi
incid
cold
month
fall
winter
fig
accord
author
alland
et
al
arnold
et
al
kesebir
et
al
preval
hbovinfect
precis
defin
detect
hbovgenom
respiratori
secret
symptomat
patient
among
hospit
children
respiratori
tract
infect
analyz
studi
rang
bastien
et
al
kaplan
et
al
major
children
hbovinfect
younger
month
alland
et
al
smut
hardi
two
recent
publish
studi
includ
control
group
asymptomat
children
kesebir
et
al
man
et
al
kesebir
cowork
isol
hbov
dna
npa
specimen
symptomat
children
none
specimen
asymptomat
children
hbov
dna
could
detect
one
hbovposit
patient
scottish
studi
asymptomat
child
man
et
al
clinic
symptom
frequent
associ
human
bocaviru
infect
includ
cough
rhinorrhea
fever
c
schenk
et
al
gastrointestin
symptom
describ
patient
arnold
et
al
kesebir
et
al
two
hbov
dna
posit
individu
present
diarrhea
one
two
patient
noroviru
detect
stool
sampl
wherea
patient
show
pathogen
stool
specimen
howev
studi
design
evalu
gastrointestin
diseas
member
parvoviru
famili
describ
cattl
caus
gastrointestin
symptom
consid
stabil
human
parvoviru
longterm
persist
hbov
inanim
environ
may
foster
fecalor
rout
transmiss
via
contamin
fomit
studi
consid
test
stool
sampl
human
bocaviru
confirm
gastrointestin
manifest
common
clinic
diagnos
hbovposit
patient
includ
upper
respiratori
tract
infect
bronchiti
bronchiol
pneumonia
exacerb
asthma
bronchial
spectrum
diagnos
accord
viral
respiratori
tract
infect
similar
situat
rsvand
hmpvinfect
william
et
al
lack
intern
consensu
definit
certain
diseas
import
clinic
context
american
academi
pediatr
smyth
openshaw
two
studi
provid
differ
definit
arnold
et
al
choi
et
al
wherea
remain
public
describ
criteria
percentag
bronchiol
within
diagnost
spectrum
rang
weissbrich
et
al
foulongn
et
al
b
public
alland
et
al
arnold
et
al
kesebir
et
al
klein
et
al
et
al
schenk
et
al
stipul
radiolog
confirm
pneumonia
similar
rsv
weigl
et
al
hmpv
distinct
clinic
sign
hbovinfect
patient
allow
etiolog
diagnosi
clinic
ground
alon
arnold
et
al
report
median
leukocyt
count
l
et
al
found
median
leukocyt
count
l
median
crp
mgl
hbovinfect
subject
confirm
find
elev
leukocyt
crpvalu
may
found
hbovinfect
children
high
percentag
patholog
find
chest
radiograph
studi
accord
result
clinic
research
group
rang
alland
et
al
foulongn
et
al
b
klein
et
al
alland
cowork
report
interstiti
bilater
infiltr
six
seven
perform
chestxray
obvious
hbov
caus
central
pneumonia
fig
also
interstiti
lobar
pneumonia
without
pleural
effus
schenk
et
al
neither
clinic
symptom
laboratori
paramet
radiolog
find
suffici
make
clear
distinct
bacteri
viral
caus
pneumonia
patient
korppi
korppi
mcintosh
result
studi
show
coinfect
rate
high
percentag
also
found
major
analyz
studi
report
coinfect
rate
alland
et
al
kaplan
et
al
rsv
preval
copathogen
studi
klein
et
al
man
et
al
detect
significantli
higher
rate
coinfect
hbovposit
patient
vs
posit
anoth
viral
pathogen
p
differ
sensit
screen
method
diagnost
panel
detect
addit
respiratori
pathogen
strongli
affect
coinfect
rate
studi
respiratori
viru
panel
includ
adenoviru
human
parainfluenza
viru
human
rhinoviru
might
contribut
even
higher
rate
coinfect
sinc
incub
period
hbovinfect
unknown
possibl
comment
incid
rate
nosocomi
infect
far
neither
studi
tenac
viru
effect
commonli
use
disinfect
soap
solut
hota
parvoviru
show
high
tenac
great
resist
commonli
use
disinfect
dowel
et
al
due
close
relationship
within
famili
parvovirida
possibl
hbov
show
similar
characterist
kesebir
cowork
report
three
patient
nosocomi
hbovinfect
n
infect
infant
month
age
hospit
sinc
birth
sequenc
two
isol
show
ident
nucleotid
sequenc
klein
et
al
describ
three
addit
hbov
dna
posit
patient
develop
respiratori
symptom
hospit
treatment
diseas
least
week
kesebir
et
al
report
three
patient
nosocomi
hbov
infect
n
vertic
transmiss
rule
author
acquir
npa
parent
none
patient
describ
studi
suspect
nosocomi
acquir
hbov
infect
centr
hbovposit
patient
receiv
antibacteri
chemotherapi
hbov
known
respons
physician
children
hbovinfect
mostli
rsvneg
patient
pneumonia
uncertain
etiolog
clinic
ill
respiratori
infect
may
explain
excess
applic
antibiot
viral
infect
respiratori
tract
frequent
associ
recurr
airway
obstruct
wheez
among
infant
asthma
exacerb
among
older
children
patient
present
wheez
lead
symptom
respiratori
infect
recent
publish
clinic
studi
hbov
report
asthma
exacerb
clinic
symptom
hbovposit
patient
arnold
et
al
foulongn
et
al
b
half
patient
studi
alland
et
al
present
asthma
bronchial
underli
diseas
recent
alland
et
al
detect
hbov
children
median
age
year
hospit
acut
wheez
larg
proport
case
mix
infect
virus
hbov
viru
detect
children
high
viral
load
hbov
note
mainli
absenc
viral
agent
suggest
caus
role
acut
wheez
addit
infect
uncertain
clinic
relev
low
viral
load
preval
hbov
dna
frequent
detect
serum
specimen
obtain
patient
acut
wheez
suggest
system
infect
recent
result
suggest
model
hbov
infect
high
viral
load
potenti
associ
respiratori
symptom
low
viral
load
indic
asymptomat
shed
therefor
quantit
polymeras
chain
reaction
analysi
may
import
addit
studi
hbov
alland
et
al
anderson
sever
clinic
research
group
report
hbovposit
immunosuppress
immunodefici
patient
studi
arnold
et
al
man
et
al
smut
hardi
arnold
et
al
present
two
pediatr
patient
hbovinfect
organ
transplant
smut
hardi
report
hbovinfect
eight
hivinfect
pediatr
patient
man
cowork
includ
two
infect
nonspecifi
immunosuppress
adult
patient
studi
arnold
et
al
man
et
al
smut
hardi
immunocompromis
individu
among
hbov
dna
posit
patient
treat
center
winter
season
group
recent
publish
clinic
case
sever
hbovinfect
femal
patient
malign
bcell
lymphoma
kupfer
et
al
admiss
patient
show
pancytopenia
high
fever
clinic
radiolog
sign
pneumonia
reticulonodular
infiltr
ctscan
thorax
despit
applic
antibiot
antifung
agent
ganciclovir
patient
present
persist
fever
day
hbov
retrospect
detect
sole
pathogen
nasopharyng
aspir
highrisk
patient
patient
discharg
day
hospit
long
limit
number
studi
compar
detect
rate
symptomat
asymptomat
peopl
fri
et
al
neither
anim
model
reliabl
cell
cultur
method
anderson
remain
difficult
confirm
koch
postul
prove
caus
role
hbov
real
pathogen
high
rate
hospit
infect
outpati
fecal
excret
hbov
shown
vicent
et
al
add
new
concern
transmiss
hbov
hbov
transmit
via
fecal
contamin
addit
respiratori
secret
human
bocaviru
preval
among
children
acut
wheez
caus
system
infect
alland
et
al
rais
question
whether
risk
parenter
transmiss
via
blood
product
blood
contamin
also
tenac
hbov
determin
yet
suscept
hospit
grade
disinfect
investig
studi
unit
state
germani
report
nosocomi
infect
kesebir
et
al
howev
due
limit
number
investig
case
true
impact
hbov
nosocomi
infect
remain
uncertain
investig
requir
addit
prospect
studi
coinfect
frequent
find
hbov
dna
posit
patient
remain
determin
whether
hbov
play
role
modifi
clinic
present
viral
respiratori
tract
infect
rsv
hmpv
point
author
collect
littl
data
evalu
probabl
bacteri
superinfect
hbov
infect
subject
sever
studi
concern
pediatr
popul
hbov
role
pathogen
adult
popul
still
investig
hbov
clinic
relev
pathogen
among
elderli
copd
patient
year
age
among
patient
underli
diseas
predispos
risk
factor
immunodefici
chronic
lung
diseas
prematur
due
retrospect
manner
data
collect
perform
studi
suffici
evalu
outcom
therapeut
intervent
could
made
point
therapeut
intervent
confirm
benefit
children
sever
hbov
infect
prospect
multicent
popul
base
studi
much
addit
work
virolog
laboratori
necessari
clear
point
